These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Provincially administered universal pharmacare programs require a secure, affordable drug supply: A matter of national security? McAlister VC Can J Surg; 2018 Aug; 61(4):220-221. PubMed ID: 30067177 [No Abstract] [Full Text] [Related]
3. Expanding Canadian Medicare to include a national pharmaceutical benefit while controlling expenditures: possible lessons from Israel. Rosen B Health Econ Policy Law; 2018 Jul; 13(3-4):323-343. PubMed ID: 29400645 [TBL] [Abstract][Full Text] [Related]
4. Prescription drugs: the facts about Canada. Consum Rep; 2005 Oct; 70(10):50-1. PubMed ID: 16163821 [No Abstract] [Full Text] [Related]
6. The relation of pharmaceutical education to the quality assurance of pharmaceutical products. Gaudry R Med Serv J Can; 1967 Mar; 23(3):376-80. PubMed ID: 6056380 [No Abstract] [Full Text] [Related]
7. The toxicity of commercial brands of sulpharsphenamine sold in Canada. LAVALLEE A; ALLMARK MG Rev Can Biol; 1948 Nov; 7(4):574-8. PubMed ID: 18099951 [No Abstract] [Full Text] [Related]
8. US eases its restrictions on prescription drugs from Canada. Kermode-Scott B BMJ; 2006 Oct; 333(7573):824. PubMed ID: 17053227 [No Abstract] [Full Text] [Related]
9. Pharmaceutical advertising in medical journals. Lexchin J Can Med Assoc J; 1984 Sep; 131(6):544-6. PubMed ID: 6478335 [No Abstract] [Full Text] [Related]
11. Should medical journals carry pharmaceutical advertising?: YES. Dehaas D Can Fam Physician; 2010 Oct; 56(10):978-80, 982-4; discussion e358, e360. PubMed ID: 20944032 [No Abstract] [Full Text] [Related]
12. Canada may be forced to allow direct to consumer advertising. Cassels A BMJ; 2006 Jun; 332(7556):1469. PubMed ID: 16793793 [No Abstract] [Full Text] [Related]
13. Should medical journals carry pharmaceutical advertising?: NO. Hoey J Can Fam Physician; 2010 Oct; 56(10):979-81, 983-5; discussion e357, e359. PubMed ID: 20944033 [No Abstract] [Full Text] [Related]
14. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia. Lexchin J; Gleeson D Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183 [TBL] [Abstract][Full Text] [Related]
15. Effect of drug patent abolition on a Canadian pharmaceutical company. LOZINSKI E Appl Ther; 1963 May; 5():441-2. PubMed ID: 13931335 [No Abstract] [Full Text] [Related]
16. CETA: a win for Canada or European pharma? Webster PC CMAJ; 2014 Oct; 186(15):E565-6. PubMed ID: 25267767 [No Abstract] [Full Text] [Related]
17. The Food and Drugs Act and quality assurance of pharmaceutical products. Allmark MG Med Serv J Can; 1967 Mar; 23(3):210-6. PubMed ID: 6056366 [No Abstract] [Full Text] [Related]
18. US pharmacists cleared to buy in cheap drugs from Canada. Spurgeon D BMJ; 2002 Jul; 325(7357):183. PubMed ID: 12143853 [No Abstract] [Full Text] [Related]
19. Canada draws near to approving Africa drugs deal. Kondro W Lancet; 2004 May; 363(9421):1615. PubMed ID: 15146892 [No Abstract] [Full Text] [Related]
20. The Dutch Pregnancy Drug Register: A Good Idea for Canada? Vorstenbosch S; Kant A; Dabekausen Y J Obstet Gynaecol Can; 2019 Apr; 41(4):407-409. PubMed ID: 30595513 [No Abstract] [Full Text] [Related] [Next] [New Search]